These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1524 related articles for article (PubMed ID: 12885899)

  • 1. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
    Bosch BJ; van der Zee R; de Haan CA; Rottier PJ
    J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.
    Bosch BJ; Rossen JW; Bartelink W; Zuurveen SJ; de Haan CA; Duquerroy S; Boucher CA; Rottier PJ
    J Virol; 2008 Mar; 82(5):2580-5. PubMed ID: 18077706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core.
    Xu Y; Liu Y; Lou Z; Qin L; Li X; Bai Z; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Jul; 279(29):30514-22. PubMed ID: 15123674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct design, biophysical, and biochemical characterization of the fusion core from mouse hepatitis virus (a coronavirus) spike protein.
    Xu Y; Cole DK; Lou Z; Liu Y; Qin L; Li X; Bai Z; Yuan F; Rao Z; Gao GF
    Protein Expr Purif; 2004 Nov; 38(1):116-22. PubMed ID: 15477089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core structure of S2 from the human coronavirus NL63 spike glycoprotein.
    Zheng Q; Deng Y; Liu J; van der Hoek L; Berkhout B; Lu M
    Biochemistry; 2006 Dec; 45(51):15205-15. PubMed ID: 17176042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.
    Xu Y; Zhu J; Liu Y; Lou Z; Yuan F; Liu Y; Cole DK; Ni L; Su N; Qin L; Li X; Bai Z; Bell JI; Pang H; Tien P; Gao GF; Rao Z
    Biochemistry; 2004 Nov; 43(44):14064-71. PubMed ID: 15518555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
    Supekar VM; Bruckmann C; Ingallinella P; Bianchi E; Pessi A; Carfí A
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):17958-63. PubMed ID: 15604146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein.
    Duquerroy S; Vigouroux A; Rottier PJ; Rey FA; Bosch BJ
    Virology; 2005 May; 335(2):276-85. PubMed ID: 15840526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
    Yuan K; Yi L; Chen J; Qu X; Qing T; Rao X; Jiang P; Hu J; Xiong Z; Nie Y; Shi X; Wang W; Ling C; Yin X; Fan K; Lai L; Ding M; Deng H
    Biochem Biophys Res Commun; 2004 Jul; 319(3):746-52. PubMed ID: 15184046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
    Matthews JM; Young TF; Tucker SP; Mackay JP
    J Virol; 2000 Jul; 74(13):5911-20. PubMed ID: 10846072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
    Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
    J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
    Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
    Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein.
    Luo Z; Weiss SR
    Virology; 1998 May; 244(2):483-94. PubMed ID: 9601516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    Biochemistry; 2005 Jan; 44(3):947-58. PubMed ID: 15654751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of the SARS-coronavirus spike S fusion protein core.
    Tripet B; Howard MW; Jobling M; Holmes RK; Holmes KV; Hodges RS
    J Biol Chem; 2004 May; 279(20):20836-49. PubMed ID: 14996844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
    J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.
    Wang E; Sun X; Qian Y; Zhao L; Tien P; Gao GF
    Biochem Biophys Res Commun; 2003 Mar; 302(3):469-75. PubMed ID: 12615056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.